December 11, 2020

COVID-19 Underwriting Update

With the continued surge in COVID-19 cases across the country, we are now seeing new records in positive cases, hospitalizations and number of deaths per day. For this reason, we need to put a hold on our plans to relax our temporary COVID-19 guidelines, and for some cases we are reinstating stricter guidelines.

We understand this is disappointing news, and we have made every effort to make these latest adjustments as minimally disruptive as possible. For this reason, we will employ a two-step approach that provides a 4-week window allowing us to monitor developments and adjust if trends improve.

Here are the adjustments to our current temporary guidelines that will go into effect in two steps beginning December 14:

Step 1, effective December 14

All pending cases for ages 70-75 will be postponed
All pending cases with a ratable BMI will be postponed

Step 2, effective January 11, 2021

All rated pending cases for ages 60-65 will be postponed
We will eliminate the use of credits on all pending cases

For your reference, here is a full overview of our updated guidelines effective December 14:

COVID-19 underwriting guidelines
Effective December 14, 2020

Age band or factor	Previous guidance	Guidance as of 12/14/20
Ages below 50	All cases assessed greater than Table D and/or all medical flat extras postponed.	No change.
Age 50-59	All cases assessed greater than Table D and/or all medical flat extras postponed.	No change.
Age 60-65	All cases assessed greater than Table D and/or all medical flat extras postponed.	No change.
Age 66-69	All rated cases inclusive of all medical flat extras postponed.	No change.
Age 70-75	All rated cases inclusive of all medical flat extras postponed.	All cases postponed.
Ages above 75	All cases postponed.	No change.
Foreign travel	Foreign travel allowed following country codes and U.S. Department of State country-by-country travel guidance.*	No change.
BMI	Cases allowed up to Table B on BMI, where rating allowed by age.	All cases with ratable BMI postponed.
Co-Morbid Conditions	AIG will continue to apply the latest medical knowledge to co-morbid conditions relative to COVID-19.	No change.

* Foreign travel not considered for the states of Florida and Georgia.

As noted, we will closely monitor COVID-19 data and the progress of vaccination efforts over the next few weeks. If the situation and forecast improve, there may be an opportunity to place the Step 2 implementation on hold. We will update you before January 11 of our plans and next steps.